These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2539768)

  • 1. Effect of the long-acting somatostatin analogue SMS 201-995 (Sandostatin) in advanced breast cancer.
    Vennin P; Peyrat JP; Bonneterre J; Louchez MM; Harris AG; Demaille A
    Anticancer Res; 1989; 9(1):153-5. PubMed ID: 2539768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.
    Weckbecker G; Liu R; Tolcsvai L; Bruns C
    Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced breast cancer: response to somatostatin.
    Stolfi R; Parisi AM; Natoli C; Iacobelli S
    Anticancer Res; 1990; 10(1):203-4. PubMed ID: 1970716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of somatostatin analogues in complete antiandrogen treatment in patients with prostatic carcinoma.
    Vainas G; Pasaitou V; Galaktidou G; Maris K; Christodoulou K; Constantinidis C; Kortsaris AH
    J Exp Clin Cancer Res; 1997 Mar; 16(1):119-26. PubMed ID: 9148872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma.
    Bajetta E; Procopio G; Ferrari L; Martinetti A; Zilembo N; Catena L; Alú M; Della TS; Alberti D; Buzzoni R
    Cancer; 2002 Jan; 94(2):299-304. PubMed ID: 11900215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analgesic effect of Sandostatin (SMS 201-995) in acromegaly headache].
    Sicolo N; Martini C; Ferla S; Roggenkamp J; Vettor R; De Palo C; Federspil G
    Minerva Endocrinol; 1990; 15(1):37-42. PubMed ID: 2274013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience in treating acromegalic patients with long-acting octreotide].
    Szücs N; Mészáros J; Czirják S; Mondok A; Varga I; Gláz E
    Orv Hetil; 2002 May; 143(19 Suppl):1066-70. PubMed ID: 12063862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells.
    Setyono-Han B; Henkelman MS; Foekens JA; Klijn GM
    Cancer Res; 1987 Mar; 47(6):1566-70. PubMed ID: 2880660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I.
    Pollak MN; Polychronakos C; Guyda H
    Anticancer Res; 1989; 9(4):889-91. PubMed ID: 2817814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].
    Laczi F; Magony S; Julesz J
    Orv Hetil; 2002 May; 143(19 Suppl):1062-6. PubMed ID: 12063861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial inhibition of the growth of transplanted dunning rat prostate tumors with the long-acting somatostatin analogue sandostatin (SMS 201-995).
    Siegel RA; Tolcsvai L; Rudin M
    Cancer Res; 1988 Aug; 48(16):4651-5. PubMed ID: 2899458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial on sms-D70 somatostatin analogue in advanced prostate and renal cell cancer.
    Joensuu TK; Nilsson S; Holmberg AR; Márquez M; Tenhunen M; Saarto T; Joensuu H
    Ann N Y Acad Sci; 2004 Dec; 1028():361-74. PubMed ID: 15650261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones.
    George SR; Hegele RA; Burrow GN
    Clin Invest Med; 1987 Jul; 10(4):309-15. PubMed ID: 2888554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies.
    Schulz S; Schulz S; Schmitt J; Wiborny D; Schmidt H; Olbricht S; Weise W; Roessner A; Gramsch C; Höllt V
    Clin Cancer Res; 1998 Sep; 4(9):2047-52. PubMed ID: 9748118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
    Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
    Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide in advanced prostatic cancer relapsing under hormonal treatment.
    Verhelst J; De Longueville M; Ongena P; Denis L; Mahler C
    Acta Urol Belg; 1994 Apr; 62(1):83-8. PubMed ID: 7515212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin analogue (SMS 201-995) in patients with gastrinomas.
    Vinik AI; Tsai S; Moattari AR; Cheung P
    Surgery; 1988 Nov; 104(5):834-42. PubMed ID: 2903562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.
    Klijn JG; Hoff AM; Planting AS; Verweij J; Kok T; Lamberts SW; Portengen H; Foekens JA
    Br J Cancer; 1990 Oct; 62(4):627-30. PubMed ID: 1977468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the long-acting somatostatin analogue SMS 201-995 on growth rate and reduction of predicted adult height in ten tall adolescents.
    Tauber MT; Tauber JP; Vigoni F; Harris AG; Rochicchioli P
    Acta Paediatr Scand; 1990 Feb; 79(2):176-81. PubMed ID: 2321479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.